Kaposi's sarcoma-associated herpesvirus (KSHV) is closely 26 associated with B-cell and endothelial cell malignancies. After the initial 27 infection, KSHV retains its viral genome in the nucleus of the host cell and 28 establishes a lifelong latency. During lytic infection, KSHV encoded lytic-related 29 proteins are expressed in a sequential manner and are classified as immediate 30 early, early, and late gene transcripts. The transcriptional initiation of KSHV late 31 genes is thought to require the complex formation of the virus specific pre-32 initiation complex (vPIC), which may consist of at least 6 transcription factors 33 (ORF18, 24, 30, 31, 34, and 66). However, the functional role of ORF66 in vPIC 34 during KSHV replication remains largely unclear. Here, we generated ORF66-35 deficient KSHV using a BAC system to evaluate its role during viral replication. 36
48
Introduction 66 KSHV, (also known as human herpesvirus 8 or HHV-8), causes 67
Kaposi's sarcoma, primary effusion lymphoma (PEL), and multicentric 68 Castleman's disease (1-3). Since the first discovery of KSHV DNA fragments in 69 a Kaposi's sarcoma lesion of an AIDS patient in 1994 (4), over a quarter of a 70 century has passed, and several aspects of KSHV pathogenesis, life-cycle and 71 viral protein function have been elucidated. Compared with other viruses, 72 herpesvirus has a large number of viral genes in its genome. KSHV encodes 73 not only viral proteins but also miRNAs and LncRNAs. These viral molecules 74 are thought to be essential for KSHV replication and its pathogenesis. One 75 characteristic of the KSHV life-cycle is the establishment of a lifelong latency in 76 the infected individual leading to KSHV-associated malignancy in patients with 77 severe immunosuppression by drugs after organ transplantation or AIDS (1) (2) (3) (4) (5) . 78
Development of KSHV-associated neoplasm occurs due to infected cells which 79 express few latent KSHV genes (including LANA, v-FLIP, Kaposin, and 80 miRNAs) (6). These genes modulate cell-proliferation and apoptosis pathways 81 (7) (8) (9) (10) (11) . Another characteristic of the KSHV life-cycle is active virus production, 82 known as lytic infection. The genes related to lytic infection have been 83 categorized into into three groups, immediate early (IE), early (E), and late (L) 84 (12, 13) . Sequential and temporal expression of KSHV genes are key to induce 85 efficient viral production during lytic infection. The IE-gene product RTA/ORF50 86 is a transcription factor for triggering transcriptional activation of another IE 87 genes and E genes, and RTA/ORF50 initiates the shift from latency to lytic 88 infection (13, 14) . The transcribed products of E genes start viral genome DNA 89 gene expression. Although ORF66 appears to be a vPIC component (18, 20, 114 22) , the importance and its function during KSHV replication remains unknown. 115 Therefore, we established ORF66-deficient KSHV, and evaluated its 116 physiological role during viral replication. Here, we show that ORF66 is 117 essential for virus production and L gene expression via interaction with ORF34. 118 119 120
Results 121
Construction of ORF66-deficient KSHV BAC. 122
We constructed ORF66-deficient recombinant KSHV BAC (ORF66-BAC16) to 123 study the impact of ORF66 during KSHV replication. Three stop codons (3-stop 124 element) were inserted into the ORF66 coding region of KSHV BAC16 using a 125 two-step markerless red recombination system (24, 25) ( Fig. 1a ). Because 126 ORF66 overlaps with ORF67 ( Fig. 1a) , the 3-stop codons were inserted within 127 the ORF66 gene to avoid interference with the coding frame of ORF67. The 128 insertion and deletion of a kanamycin resistance gene (Kan R ) were analyzed by 129
EcoRV-digestion ( Fig. 1b) . Mutations and the insertion of the 3-stop codons into 130 ORF66-BAC16 were confirmed by Sanger sequencing (Fig. 1c) . 131 132 ORF66 deficiency abrogates virus production and late gene expression. 133
To efficiently induce recombinant KSHV, tetracycline-inducible (Tet-on) 134 RTA/ORF50-expressing SLK cells (iSLK) and Vero cells (iVero) were used as 135 virus producer cells (20) . Recombinant KSHV BAC clone, wild type (WT)-136 BAC16 or ORF66-BAC16, was transfected into iVero or iSLK cells, and then 137 selected with hygromycin to generate recombinant KSHV-inducible stable cell 138 lines, iVero-WT, iVero-ORF66, iSLK-WT, and iSLK-ORF66. To evaluate 139 whether ORF66 is critical for KSHV replication, virus production and virus 140 genome replication in iSLK-ORF66 and iVero-ORF66 cells were analyzed. 141 iSLK-WT, iSLK-ORF66, iVero-WT, and iVero-ORF66 cells were treated with 142 Dox and NaB, and culture supernatants were harvested. The amount of KSHV and ORF66-KSHV in iSLK or iVero culture supernatants were 144 measured by real-time PCR ( Fig. 2a and 2e ). As a result, the production of 145 ORF66-KSHV in iSLK and iVero cells were about 1000-fold and 100-fold lower 146 than WT-KSHV. In contrast, there was no significant difference in cell-147 associated KSHV DNA levels between WT-KSHV and ORF66-KSHV 148 producing cells ( Fig. 2b and 2f ). Next, to clarify that the reduction of virus 149 production in iSLK-ORF66 and iVero-ORF66 cells is caused by ORF66-150 deficiency, we tested whether exogenous ORF66 expression could rescue virus 151 production of iSLK-and iVero-ORF66 cells. The iSLK-ORF66 and iVero-152 ORF66 cells stably transfected with empty plasmid or ORF66 expression 153 plasmid were cloned by neomycin (G418) or blastcidin S. The protein 154 expression levels of exogenous 3xFLAG-tagged ORF66 were confirmed by 155
Western blotting ( Fig.2c and 2g ). Virus production from iSLK-ORF66 and 156 iVero-ORF66 cell lines was partially but significantly recovered when 3xFLAG-157 ORF66 was exogenously expressed ( Fig.2d and 2h ). These results indicate that 158 ORF66 is crucial for KSHV replication and may function in steps following viral 159 DNA replication. 160
To evaluate the contribution of ORF66 on KSHV gene expression, we 161 performed an RT-qPCR array on viral gene. Total RNA was extracted from 162 iSLK-WT and iSLK-ORF66, stimulated with NaB and Dox for 72 hours. RNA 163 was subjected to RT-qPCR array as previously reported (26). Our data showed 164 a broad reduction of KSHV mRNA in iSLK-ORF66 compared to iSLK-WT 165 ( Fig.3 ), where 7 out of the top 10 down-regulated genes were late genes (K8.1, 166 ORF17, ORF26, ORF27, K9, ORF75, ORF25) . In particular, K8.1, ORF26, 167 ORF27, and ORF25 have been previously reported by Nandakumar et al (27) 168 as direct vPIC targets. In contrast to L genes, Latent and IE genes were mildly 169 down-regulated. 170
If ORF66 functions as a vPIC component, we hypothesized that it 171 would be recruited to the "TATT"-box, which is known to be located 172 approximately 30 bp upstream of the transcription start site (TSS) of L genes 173 (27) . To demonstrate this, we evaluated whether ORF66 interacts with L gene 174 promoters by ChIP assay. iSLK-ORF66 and iVero-ORF66 cells stably 175 expressing 3xFLAG-ORF66 were treated with or without NaB and Dox to induce 176 lytic infection, and then cells were subjected to ChIP assay using anti-FLAG 177 antibody ( Fig. 4) . As a result, immunoprecipitated ORF66 was found to be 178 bound to the promoters of K8.1 (L gene) but not to the promoters of latent gene 179 (ORF72), IE gene (ORF16) and E gene (ORF46/47). These results indicated 180 that a protein complex bearing ORF66 may interact with L gene promoters via 181 an interaction between ORF24 and ORF66. 182
183
The interaction of ORF66-ORF34 and its function in viral production. 184 ORF66 was reported to interact with other vPIC components such as 185 ORF31, ORF18 and ORF34 by us and others (18, 20, 22) . We also found that 186 ORF34 operated as the vPIC hub, by bridging ORF24 and vPIC components 187 including ORF66. Furthermore, these interactions are thought to be important 188 for functions of vPIC in gene expression. To gain further insight into the 189 interaction between ORF66 and ORF34, we identified the responsible region 190 within ORF66 for binding with ORF34. We made ORF66 truncated mutants that 191 each had approximately 60 amino acid deletions spanning from the N-terminus 192 to C-terminus of ORF66 (Fig. 5a ). The interaction between ORF66 mutants and 193 ORF34 was assayed by pull-down experiments (Fig. 5b ). 293T cells were co-194 transfected with 2xS-ORF66 mutants and 6xMyc-ORF34 plasmids, and 2xS-195 ORF66 were precipitated from cell extracts by S-protein-immobilized beads. As 196 a result, ORF66 1-4 truncated mutants interacted with ORF34. However, no 197 interaction with ORF66 5-7 truncated mutants was observed, meaning that 198 the C-terminal region (241a.a.-429a.a.) of ORF66 is critical for ORF34 binding. 199
Furthermore, we performed a trans-complementation assay using these 200 truncation ORF66 mutants to assess how the loss of ORF34-ORF66 interaction 201 affects virus production. ORF66 mutant plasmids were transfected into iSLK-202 ORF66 and iVero-ORF66, and recovery of virus production was measured. 203
Wild type ORF66 expression significantly increased viral production in iSLK-204 ORF66 and iVero-ORF66 cells, while recovery of virus production was not 205 detected by expressing any of the ORF66 truncated mutants ( Fig. 5c and 5d ). 206
These results indicate that not only the ORF66 C-terminal domain (i.e., ORF34-207 binding region) but also the entire structure of ORF66 are indispensable for 208 virus production. 209
An amino-acid sequence alignment of the ORF66 C-terminal domain 210 of KSHV and other herpes virus homologs are depicted in Fig. 6a . Conserved 211 amino acids are indicated with a gray background. To identify the key residues 212 in the ORF66 C-termial region for interaction with ORF34, we constructed block 213 alanine-scanning mutants (CR1mut to CR9mut), where several neighboring 214 conserved amino-acids were substituted to alanine ( Fig. 6a ), except for proline 215 to avoid disruption the whole protein structure. These mutants were subjected 216 to pull-down assays to investigate the association of ORF34. Results showed 217 that ORF66 CR2, 3, 4 and 6 mutants bind to ORF34, whereas ORF66 CR1, 5, 218 7, 8 and 9mut did not bind ( Fig. 6b ). Therefore, we focused on specific amino 219 acid sequences of mutants losing the ability to bind to ORF34. In particular, 220 CR1, 5, and 9mut have mutations in the C-X-X-C consensus sequence. On the 221 other hand, CR7 contains a single cysteine residue, and CR8 contains three 222 leucine residues. 223
To obtain farther insight into ORF34 binding via CR1 to CR9 of ORF66 224 in viral production, ORF66 alanine substitution mutants (CR1 to CR9) were 225 subjected to trans-complementation assay using iSLK-ORF66 and iVero-226 ORF66 cells ( Fig. 7a and 7b ). Compared with ORF66 wild type expression, 227 virus production in both iSLK-ORF66 and iVero-ORF66 cells could not be 228 recovered by the expression of CR1, 5, 7, 8 and 9mut, which failed to interact 229 with ORF34 ( Fig. 6b ). On the other hand, expression of CR2, 3, 4 and 6mut that 230 maintained interaction with ORF34 showed varying levels of recovery, indicated 231 by red columns (Fig. 7a-b ). CR3 and 6mut showed almost the identical levels of 232 recovery compared with ORF66 wild-type in iVero-ORF66 cells and partial 233 recovery in iSLK-ORF66 cells. Recovery by the CR4mut was significant, 234 however, lower than those of CR3 and 6mut. CR2mut had no effect. These data 235 revealed that the binding between ORF66 and ORF34 via the conserved 236 amino-acids of CR1, 5, 7, 8 and 9 regions in ORF66 is necessary, but not 237 sufficient for virus replication. 238
239
The C-X-X-C sequences and Zinc binding of ORF66 are important for 240 association with ORF34. 241
Based on our results of ORF66 alanine scanning mutants, we found 242 that CR1, CR5 and CR9 regions of ORF66 contain a C-X-X-C sequence which 243 is critical for ORF34 binding (Fig. 6a ). Therefore, we generated expression 244 plasmids with single amino acid mutants ORF66 C295A, C298A, C341A, 245 C344A, C424A and C427A in which a cysteine in C-X-X-C was substituted with 246 an alanine. Plasmids of ORF66 G299A, S342A, G345A and G345A mutants in 247 which the conserved glycine or serine around the C-X-X-C sequence was 248 substituted with alanine were also generated. The plasmids of 6xMyc-ORF34 249 and ORF66 alanine mutants were co-transfected into cells, and cell extracts 250 were subjected to affinity purification using S-protein immobilized beads, 251 followed by Western blotting. As a result, C295A, C298A, C341A, C344A, 252 C424A and C427A ORF66 mutants failed to interact with ORF34 ( Fig 8a, b and 253 d). Furthermore, two leucine residues at 412 and 413 in CR8 of ORF66 were 254 also important for the association with ORF34 (Fig 8c) . These results suggest 255 that a conserved leucine-repeat (412L and 413L) in CR8 and three conserved 256 C-X-X-C sequences in CR1, 5 and 9 are needed for binding to ORF34, leading 257 to the appropriate formation of vPIC. Because the C-X-X-C motif in proteins is 258 often related to the binding to bivalent-cation, we speculate that C-X-X-C 259 sequence contributes to form a higher order structure such as a zinc-finger 260 domain. Next, to elucidate whether capturing zinc ion within ORF66 is 261 necessary for binding to ORF34, we performed pull-down assays using zinc 262 chelator TPEN and 2xS-ORF66-conjugated S-protein beads. The ORF66-263 conjugated beads were mixed with the cell extracts including overexpressed 264
Myc tagged ORF34 in the presence of TPEN and were pull-down. The 265 precipitates were subjected to western blotting with anti-Myc. As a result, TPEN 266 decreased the interaction of ORF66 with ORF34, indicating that ORF66 may be 267 a zinc-binding protein (Fig. 8e) . 268
269
Discussion 270 The C-terminus of ORF66 is highly conserved among herpesvirus 271 homologs compared with the N-terminus ( Fig.6a ). We prepared alanine-272 scanning mutants of ORF66 for amino acid residues that are conserved among 273 MHV, BHV, EBV, HCMV, and HHV-6. The conserved amino acid regions of 274 CR1, 5, 7, 8 and 9 in the ORF66 C-terminal domain is necessary for the binding 275 between ORF66 and ORF34, and virus production. In addition, three conserved 276 C-X-X-C sequences in ORF66 CR1, 5 and 9 were needed for binding to ORF34 277 ( Fig. 8 ). Our results indicate that ORF66 leads to appropriate vPIC formation by 278 the interaction of ORF34 via C-X-X-C sequences in the C-terminal domain of 279 ORF66. We speculate that the conserved C-X-X-C sequences could form a 280 higher order structure such as a zinc-finger domain. Therefore, we approached 281 the protein structure and functional prediction of ORF66 by a server-based 282 helical protein structure simulation, I-TASSER (Iterative Threading ASSEmbly 283 Refinement) (28-30) and generated a full-length homology model of ORF66 284 ( Fig. 9 ). According to a meta-server approach to protein-ligand binding site 285 prediction (COACH) (31, 32), four cysteine residues, C295, C298, C341, and 286 C344 are predicted to associate with a zinc ion. Based on the location of each 287 cysteine residue in the homology model, a pair of cysteines, C295/C298 in 288 CR1/CR2 or C341/C344 in CR5, might chelate a single molecule of zinc, which 289 correlates with our experimental observation using a zinc chelator, TPEN ( Fig.  290 
8). The zinc chelator TPEN inhibited association between ORF66 and ORF34. 291
This result indicates that ORF66 binds zinc, which is important for its interaction 292 with ORF34. We also performed homology searching of ORF66 by SWISS-293 model. Interestingly, 319-348 amino acids (including CR5 region) of ORF66 294 have low homology with the TFIIB zinc-ribbon domain of hyperthermophilic 295 archaea Pyrococcus furiosus. As these zinc-associated cysteine residues were 296 mostly located inside the protein structure, except for C341 ( Fig. 9 ; middle 297 panel), it is implies that CR1, CR2, and CR5 residues are involved in 298 maintaining the functional structure formation of ORF66 via zinc interaction. 299
Two leucine residues (L412 and L413) in LLQL of CR8 are essential 300 for binding between ORF66 and ORF34 ( Figure 6b and 8c), suggesting that the 301 hydrophobicity of a leucine-rich sequence is also indispensable for ORF66 to be 302 functional. In fact, L412 and L413 residues in CR8 are predicted to be fully 303 exposed on the protein surface, which represented a high degree of 304 hydrophobicity by our structural model ( Fig. 9 ). Two cytosine residues (C424 305 and C427) in CR9 were not predicted to be a zinc-binding domain by our 306 protein-ligand binding prediction, however these residues in ORF66 were also 307 responsible for ORF34 interaction ( Figure 6 ). These residues are exposed on 308 the protein surface ( Figure 9 ; middle panel), and located at the hydrophobic 309 surface including LLQL motif ( Figure 9 ; right panel). Thus, the hydrophobic 310 region surrounding two leucine residues in CR8 and cysteine residues in CR9 is 311 expected to make up the binding surface and be directly involved in the 312 hydrophobic interaction with ORF34. 313
We evaluated the viral replication in KSHV ORF66-producing iVero 314 and iSLK cells, which were stably integrated with an ORF66-dificient KSHV 315 BAC clone. ORF66 plays a critical role in virus production and the transcription 316 of L genes. KSHV ORF24 binds to ORF34, RNA pol II and the TATT-box of the 317 transcriptional start site (TSS) of the L gene (18, 20, 21) . Because direct or 318 indirect interaction of ORF34 with ORF 18, 30, 31 and 66 were indicated by co-319 immunoprecipitation and split luciferase experiments (18, 20, 21) , ORF34 has 320 been thought to function as a hub for interactions between ORF24 and other 321 vPIC components. Therefore, these reports, in addition to our viral replication 322 kinetics and viral gene expression data imply that ORF66 engages in L gene 323 expression as a vPIC component. These results are in line with other 324 herpesvirus homologs of KSHV ORF66. For instance, EBV BFRF2 is essential 325 for virus production and contributes to vPIC formation (33). HCMV UL49 is also 326 essential for replication in human foreskin fibroblasts (34, 35) . 327
To gain a better understanding of ORF66 within the vPIC complex, we 328 attempted to search for ORF34-binding regions within ORF66. Pull-down 329 assays using truncated ORF66 mutants showed that the C-terminal region 330 (from 241 a.a. to 429 a.a/the C-terminus end) of ORF66 was responsible for 331 binding to ORF34 (Fig. 5b ). And the truncated ORF66 mutants were subjected 332 to a trans-complementation assay. However, all truncated ORF66 mutants did 333 not rescue virus productions in both KSHV-ORF66 iVero and iSLK cell lines 334 ( Fig. 5c and 5d ). Therefore, we speculate that the entire structure of ORF66 is 335 necessary for virus production through vPIC formation. Considering the 336 complex structure of human PIC components (TBP and GTFs) and RNAPII 337 (36), vPIC is might be a crowded complex that consists of not only vPIC factors 338 but also host proteins such as RNAPII, RNAPII binding proteins, and other 339 unknown host. Lacking large regions of ORF66 may also influence the overal 340 structure of the protein and affect interaction with its binding partners. Another 341 possibility is that the N-terminal and center regions of ORF66 are related to 342 interaction with other vPIC components or unknown host factors. 343
To evaluate the physiological function of conserved amino acids, block 344 alanine-scanning mutants of ORF66 were subjected to a trans-complementation 345 assay. The ORF66 mutants (CR1, 5, 7, 8 and 9mut) failed to associate with 346 ORF34 (Fig. 6 ) and could not rescue virus production in KSHV-ORF66 cell 347 lines (Fig. 7) . In contrast, some ORF66 mutants (CR3 and 6mut), which 348 associate with ORF34, showed full or partial rescue activities, while CR2mut did 349 not. Presumably, the conserved sequence (CLNxG) in the CR2 region is related 350 to binding to other vPIC associated factors. ORF66 rescued activity in iSLK/ 351 66 and iVero/ 66 cell lines, however, recovery rates were lower in iSLK/ 66. 352
The differences in the recovery rates of both cell lines may be due to KSHV 353 production potential and/ or characteristics of each cell line. Efficiency of KSHV 354 production in iSLK is 100-fold higher than iVero. Furthermore, iVero is derived 355 from non-human primates, African green monkey. For maintenance, iSLK cells were cultured in growth medium containing 1 400 μg/mL of puromycin (InvivoGen, CA, USA) and 0.25 mg/mL of G418 (Nacalai 401 Tesque, Kyoto, Japan). iVero cells (20) were cultured in a growth medium 402 containing 2.5 μg/mL of puromycin. KSHV BAC16 wild-type (WT-BAC16) and 403 mutant (ORF66-BAC16) were transfected to iSLK and iVero cells. iSLK and 404 iVero cells were transfected by a calcium phosphate and a lipofection method, 405 respectivly. Transfected cells were selected under 1000 μg/mL of hygromycin B 406 (Wako, Osaka, Japan) and 2.5 μg/mL of puromycin to establish doxycycline-407 inducible recombinant KSHV producing cell lines (iSLK-WT, iSLK-ORF66, 408 iVero-WT, iVero-ORF66). 409
To establish stable ORF66-expressing cells, pCI-blast-3xFLAG-ORF66 410 and empty vector (pCI-blast-3xFLAG) were transfected into iSLK-WT or iSLK-411 ORF66 cells, and transfected cells were selected in 10 μg/mL of Blastcidin S 412 (InvivoGen) and maintained in 7.5 μg/mL of Blastcidin S. Thus, stable cell lines, 413 iSLK-WT/pCI-blast-3xFLAG, iSLK-ORF66/pCI-blast-3xFLAG and iSLK-414 ORF66/pCI-blast-3xFLAG-ORF66, were established. To establish iVero-WT/ 415 pCI-neo-3xFLAG, iVero-ORF66/ pCI-neo-3xFLAG, iVero-ORF66/ pCI-neo-416 3xFLAG-ORF66 stable cell lines, iSLK harboring each KSHV BAC clone was 417 selected and maintained in 1.5 mg/mL of G418. 418 419 420
Measurement of virus production and viral DNA replication. 421
For quantification of virus production, KSHV virions in culture supernatant were 422 quantified as previously described (20, 40, 41) . Briefly, iSLK and iVero cells 423 (iSLK-WT, iSLK-ORF66, iVero-WT, or iVero-ORF66) were treated with 424 Sodium Butyrate (NaB) and doxycycline (iSLK; NaB 0.75 mM/ Dox 4 μg/mL, 425 iVero; NaB 1.5 mM/ Dox 8 μg/mL) for 72 hours to induce to lytic replication and 426 production of recombinant KSHV, and culture supernatants were harvested. 427
Culture supernatants (220 μL ChIP assay was performed as described previously (43) Table 1 . 475 476
Pull-down assay, Western blot, and antibodies. 477
Western blots were performed as described previously (20) 
Statistics. 512
The two-tailed student's t-test was used to indicate the differences between the 513 groups. P values are shown in each figure. 514
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The (c) iSLK-ORF66 or (d) iVero-ORF66 cells were transfected with control, 587 ORF66 or ORF66-truncated mutant plasmid. Transfected cells were stimulated 588 for 3 days. Progeny KSHV was purified from harvested culture supernatant, and 589 the KSHV genome was quantified by real-time PCR. Viral productivity was 590 assessed using four independent samples, and error bars indicate standard 591 deviations. Transfected virus producing cells were lysed and subjected to 592
Western blotting to confirm ORF66 mutant expression. 593 BAC16; Accession number GQ994935), MHV68 ORF66 (strain WUMS; 600 NC_001826), BHV4 ORF65 (strain V; JN133502), EBV BFRF2 (strain B95-8; 601 V01555), CMV UL49 (strain Towne ; FJ616285), HHV6 U33 (strain japan-a1; 602 KY239023)). Raw data of alignment were obtained by using Clustal Omega 603 (EMBL-EBI; https://www.ebi.ac.uk/Tools/msa/clustalo/). Completely conserved 604 amino acids between homologs were indicated by a gray background. Based 605 on this information, several conserved amino acids were split into blocks of 606 alanine scanning ORF66 mutants (CR1mut; ORF66 C295A/C298A/G299A, 607
CR2mut; ORF66 C301A/L302A/N303A/G305A, CR3mut; ORF66 F314A/F320A, 608
CR4mut;
ORF66 R323A/D324A/E327A/K328A, CR5mut; ORF66 609 C341A/S342A/C344A/G345A, CR6mut; ORF66 V371A/N375A, CR7mut; 610 ORF66 C393A, CR8mut; ORF66 L412A/L413A/L415A, CR9mut; ORF66 611 C424A/C427A). 612 (b) Block alanine scanning mutants were co-transfected with expression 613 plasmids of 6xMyc-ORF34. Cell lysates were subjected to pull-down assays 614 using S-protein immobilized beads. 615 616 Fig.7 . Association between ORF66 and ORF34 is necessary but not 617 sufficient for virus production 618
The (a) iSLK-ORF66 or (b) iVero-ORF66 cells were transfected with control, 619 ORF66 or ORF66 block alanine scanning mutant plasmid. Progeny KSHV was 620 purified and the KSHV genome was quantified. Viral productivities were 621 assessed using three independent samples, and error bars indicate standard 622 deviations. The colour of each bar indicates the following: Black, control; Gray, 623 ORF66 WT; Blue, ORF66 alanine scanning mutants not binding to ORF34; 624
Red, ORF66 alanine scanning mutants binding to ORF34. Transfected virus 625 producing cells were lysed and subjected to Western blotting analysis for the 626 confirmation of ORF66 mutant expression. 627 ORF66 wild-type, block alanine scanning mutants and single alanine scanning 631 mutants were co-transfected with expression plasmids of 6xMyc-ORF34. Cell 632 lysates were subjected to pull-down assays using S-protein immobilized beads. 633
Blotting showed the association between ORF34 and (a) CR1 mutants 634 (CR1mut; ORF66 C295A/C298A/G299A, ORF66 C295A, ORF66 C298A, 635
ORF66
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WT-BAC16

ΔORF66-BAC16
3-stop element ORF17  ORF26  ORF27  ORF75  ORF45   K9/ vIRF1  ORF39  ORF25  ORF46  ORF33  ORF37  ORF38  ORF52  ORF28  ORF4  ORF55  ORF8  ORF42  ORF9  K10  ORF32  vIRF3  ORF47  ORF65  ORF31  ORF30  ORF22_2  ORF19   K11  ORF34  ORF22_1  ORF53  ORF63   K1  ORF48  ORF64  ORF18  ORF21  ORF36  ORF10  ORF74  ORF56  ORF43  ORF49   K4  ORF29  ORF11  ORF62  ORF16  ORF61  ORF60  ORF7  K14  ORF41  ORF58  ORF59  ORF40  ORF35  K-bZIP  ORF67   K7/ PAN  ORF66  ORF24  K12  ORF54  ORF73  ORF23  ORF72  ORF57  ORF6  ORF70  ORF2  ORF69   K3  K6_1  ORF71  K6_2  ORF44  ORF68  K5_2  K5_1 
Control IgG
Anti-FLAG
Anti-FLAG Control IgG P A C E ------------------ 
KSHV 271 I P V I C S R V A R -------A A L A K R A R C A R A V V C M E C G H C L N F G R G K F ---H T V N F P P T N V F
320 253 L P I L S R A L A D ---------L A L T G H G H Q I T V C N E C G H C L N L G R D K F ---L A V N F S P T S M F 300 272 L P I L S R G V -L -------T S I G E K G T V Q K F V T C L D C G H C L N F G R G K F ---K T I N F L P T N I F 320 358 V P A A G P R A Y K C F R S H A S R P V S G P D Y P P L A V F C M D C G Y C L N F G K Q T G V G G R L N S F R P T L Q F 417 350 L P L W C L C R L K C E R H L D -------A R S L V A V V C R Q C G H C L N L G K E K L H --C Q Q N F P L N S M F 400 279 L P V M C Y C K T K C S R F I L -------E E S Y I C V I C A K C G H C L N S G K E K L C --S P Q G F S L S S M F 329 MHV68 BHV4 EBV CMV HHV6
KSHV 321 F S R D R K E K Q F T I C A T T G R I Y C S Y C G S E H M R V Y P L C D I T G R G T L ----A R V V I R A V L A N N
A 376 301 Y C R D Q K E K Q F N I C A T T G R I Y C S Y C G A T E F T V Y D M V G R Y A T -------G E P F I R A V S S A N S 353 321 Y C R D Q K E K Q A V I C A T T G R I Y C S Y C G S S H I T V L P M M G S D K K I --------S Y L R A V I S N N A 372 418 Y P R D Q K E K H V L T C H A S G R V Y C S N C G S A A V G C Q R L A E P P S A R S G ----W R P R I R A V L P H N A 473 401 Y Y R D R Q E K S V I F N T H A E L V H C S L C G S Q R V V R Q R V Y E L V S E T L F G Q R C V R V G W K A V L G L N A 460 330 Y F R D K Q E K N L I Y S M H T D V M Y C S L C G S Q Q L V F E R I Y E M S E H C V L G M K V K T V S W K A V I G T N S 389 MHV68 BHV4 EBV CMV HHV6
KSHV 377 A L A I R D L D Q T V S F V V P C L G T P D C E --A A L L K H R D V R G L L Q L T S Q L L E -F C C G K C S S ----
Cartoon model
Surface model Hydrophobicity model 
